A prospective study of 25 newly diagnosed thyrotoxic patients was undertaken to determine the incidence and severity of ophthalmopathy in the early stages of the disease. A quantitative analysis of the ocular muscle changes was made using B scan ultrasonography, and the effects of treatment for the thyroid disease on the course of the eye changes was assessed. Although the majority (75%) of patients showed only mild clinical signs of ophthalmopathy (Werner Class 3 or less), 92% had ultrasonographic evidence of ocular muscle enlargement. Clinical involvement of the extraocular muscles was seen in 12% of the cases. There was an inverse correlation between the serum level of thyroid stimulating hormone receptor antibody (TR Ab) and the size of the extraocular muscles. Recovery of the euthyroid state with treatment was accompanied by a decrease in orbital infiltration in some cases, both clinically (reduced amplitude of intraocular pressure rise on elevation of the globe) and by ultrasonography, but the improvement was not statistically significant.
GravesRJ. (1835); Clinical Lectures. London Med. & Surg. J. (Pt. II)7: 516–517.
2.
WernerSC, ColemanDJ, FranzenLA. (1974); Ultrasonographic evidence of a consistent orbital involvement in Graves' disease. N. Engl. J. Med; 290: 1447–1450.
3.
ColemanDJ, JackRL, FranzenLA, WernerSC. (1972); High resolution B-scan ultrasonography of the orbit. Part V. Eye changes of Graves' disease. Arch. Ophthalmol;88: 465–471.
4.
ForresterJV, SutherlandGR, McDougallIR. (1977); Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography. J. Clinical Endocrinol & Metabolism; 45: 221–224.
5.
TrokelSL, JackobiecFA. (1981); Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology88: 553564.
6.
KonishiJHermanMM, KrissJP. (1975); Binding of thyroglobulin antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology; 95: 434–446.
7.
VolpeR. (1978); The pathogenesis of Graves' disease. J. Clinical Endocrinol and Metab; 7: 3.
HallR, SmithBR, MukhtarFD. (1975); Thyroid stimulators in health and disease. J. Clin. Endocrinol & Metab; 4: 213.
10.
KrissJP, KonishiJ, HermanMM. (1975); Studies on the pathogenesis of Graves' ophthalmopathy. Recent Prog. Hormone Res; 31: 533–566.
11.
AdamsDD, KennedyTH. (1967); Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralisation by an extract of thyroid gland. J. Clin. Endocrinol & Metab; 27: 173–177.
12.
MahieuP, WinardR. (1972); Demonstration of delayed hypersensitivity to retro-bulbar and thyroid tissue in human exophthalmos. J. Clin. Endocrinol & Metab; 34: 1090–1092.
13.
MunroRE, LamkiL, RowW. (1973); Cell-mediated immunity in exophthalmos of Grave's disease as demonstrated by the inhibition factor (MIF) test. J. Clin Endocrinol & Metab; 37: 286–292.
14.
SridamaV, PaciniF, DeGrootLJ. (1982); Decreased suppressor T-lymphocytes in autoimmune thyroid disease detected by monoclonal antibodies. J. Clin. Endocrinol & Metab; 54: 316–319.
15.
WilsonR, McKillopJH, PearsonDWM, CuthbertGF, ThomsonJA. (1985); Relapse of Graves' disease after medical therapy: Predictive value of thyroidal 99m TC uptake and serum TSH receptor antibody levels. J. Nucl. Med; 26: 1024–1028.
16.
WernerSC. (1977); Modification of the classification of the eye changes of Graves' disease. Am. J. Ophthalmol; 83: 725–727.
17.
ColemanDJ, SmithME. (1978); Hyperthyroidism, ultrasonic evaluation of eye changes. In ‘The Thyroid. A fundamental and clinical text’, 4th Edition, p 671–675. Edited by Werner SC & Ingbar SH. Harper & Row, Publishers.
18.
ShammasHJ, MincklerDS, OgdenC. (1980); Ultrasound in early thyroid orbitopathy. Arch Ophthalmol; 98: 277–279.
19.
GamblinG, HarperD, GalentineP. (1983); Prevalence of increased intraocular pressure in Graves' disease — evidence of frequent subclinical ophthalmopathy. The New Eng. J. of Medicine; 308: 420–424.
20.
LyonsDE. (1971); Postural changes in IOP in dysthyroid exophthalmos. Trans. Ophthalmol. Soc. UK; 91: 799–803.
21.
ZappiaRJ, WinkelmanJZ, GayAJ. (1971). Intraocular pressure changes in normal subjects and the adhesive muscle syndrome. Am. J. Ophthalmol;71: 880–883.
22.
OssoiningKC. (1984). Ultrasonic diagnosis of Graves' ophthalmopathy. In ‘The eye and orbit in thyroid disease’. Edited by GormanCARaven Press, NY. p 185–211.
23.
OssoiningKC. (1971); Echo-orbitography, a reliable method for the differential diagnosis of endocrine exophthalmos. In FellingerL, HoferR. (Eds): Further advances in thyroid research. ViennaG, Gistel & Co. p 871–877.
FeldenS, WeinerJ. (1982); Clinical significance of extraocular muscle volumes in Graves' ophthalmopathy. Arch. Ophthalmol; 100: 1266–1269.
26.
TengCS, SmithBR, ClaytonB. (1977); Thyroid stimulating antibodies to the immunoglobulins in ophthalmic Graves' disease. Clin. Endocrinol; 6: 207–212.
27.
McKenzieJM, McCullaghEP. (1968); Observations against a casual relationship between long-acting thyroid stimulator and ophthalmology in Graves' disease. J. Clin. Endocrinol. Metaba; 28: 1172.
28.
WallJR, StrakoschCR, FangSL, IngbarSH, BravermanLE. (1979) Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide. Clin. Endocrinol;10: 79–91.
29.
KrissJP & MehdiSQ. (1979); Cell mediated lysis of lipid vesicles containing eye muscle proteins: implications regarding the pathogenesis of Graves' ophthalmopathy. Proc. Natl. Acad. Sci. USA; 76: 2003–2007.
30.
BlanHM, KaplanI, TaoTW & KrissJP. (1983). Thyroglobulin-independent cell mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci;3: 245–253.
31.
KodamaK, Bandy-DafoeP, SikorskaH, BaylyR, WallJR. (1982); Demonstration of a circulating auto-antibody against a soluble eye muscle antigen in Graves' opthalmopathy. Lancet; 2: 1353–1356.
32.
Kendall-TaylorP, AtkinsonS & HolcombeM. (1984); A specific Ig G1 in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Brit. Med. J; 288: 1183.
33.
DumondeDC, Kasp-GrochowskaE, GrahamE, SandersMD, FaureJP, de KozakY, van TuyenV.Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet;2: 787–792.
